How are vitamins named?

The naming of vitamins follows a historical and somewhat haphazard convention rooted in early 20th-century nutritional science, where newly discovered essential micronutrients were sequentially assigned letters of the alphabet as they were identified. This process began with "vitamine," a term coined by Casimir Funk in 1912 to describe vital amines, and though the 'e' was later dropped when not all were amines, the letter-based system persisted. The initial sequence—A, B, C, D, E—was established based on the order of discovery or differentiation from known substances. However, this linear progression quickly became complicated; for instance, what was once thought to be a single "vitamin B" was later found to be a complex of several chemically distinct factors, leading to the subdivision into B1 (thiamine), B2 (riboflavin), B3 (niacin), and so forth up to B12 (cobalamin). Gaps in the sequence, such as vitamins B4, B8, B10, and B11, represent compounds that were either reclassified as non-essential, redundant, or not vitamins at all, highlighting the iterative and often messy nature of early biochemical research.

The nomenclature is not purely alphabetical but reflects a combination of chemical understanding and historical accident. After the initial lettered vitamins were established, later discoveries sometimes received letter designations based on perceived relationships, as with vitamin K for "Koagulation" from the Danish spelling, or were simply incorporated into existing groups, like the various forms of vitamin E (tocopherols and tocotrienols). Crucially, the letter names are generic descriptors for biological activity, not specific chemical entities. Each letter can encompass multiple related compounds, known as vitamers, that all fulfill the same essential function in the body. For example, "vitamin A" refers to retinol, retinal, and retinoic acid, among others. The system also reveals geographical and disciplinary divides; substances considered vitamins for humans, like vitamin C (ascorbic acid), are not vitamins for all species, as most animals can synthesize it internally.

The modern scientific naming of vitamins increasingly relies on precise chemical nomenclature or generic descriptors that define function, though the legacy letters remain in common and clinical use. The B vitamins and vitamin C are water-soluble, while vitamins A, D, E, and K are fat-soluble, a classification with profound implications for their metabolism, storage, and toxicity, which the letter system alone does not convey. Today, the discovery phase is essentially complete; no new substances have been granted a vitamin letter for humans in decades, as the set of 13 is now well-defined. The existing names are thus historical artifacts, preserved due to their entrenchment in medical, nutritional, and public health discourse. This dual system—historical letters alongside systematic chemical names—creates a useful, if imperfect, bridge between scientific specificity and public recognition.

The implications of this naming convention are significant for both science communication and regulatory policy. The persistence of letter names can sometimes obscure the complexity of vitamin nutrition, leading to a public perception of vitamins as monolithic entities rather than families of compounds with varying potencies and sources. In scientific literature and supplement labeling, there is a move toward greater precision, specifying forms like "cyanocobalamin" or "methylcobalamin" instead of just "B12." However, the legacy system endures because it provides a functional shorthand that is universally understood. It serves as a reminder that scientific classification is often shaped by the historical path of discovery, where provisional labels can become permanent fixtures, even as our underlying chemical and physiological knowledge advances far beyond the original, simplistic alphabetical framework.